Press coverage about Cantel Medical Corp. (NYSE:CMD) has trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Cantel Medical Corp. earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 45.5140051170751 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

These are some of the news headlines that may have impacted Accern Sentiment Analysis’s scoring:

Several equities research analysts have recently issued reports on the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Cantel Medical Corp. in a research note on Friday, September 1st. Zacks Investment Research lowered Cantel Medical Corp. from a “hold” rating to a “sell” rating in a research note on Monday, June 5th. Benchmark Co. lowered Cantel Medical Corp. from a “buy” rating to a “hold” rating in a research note on Friday, June 9th. Finally, Sidoti raised Cantel Medical Corp. from a “neutral” rating to a “buy” rating and set a $92.00 price objective for the company in a research note on Wednesday, August 2nd. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $91.67.

Shares of Cantel Medical Corp. (NYSE CMD) opened at 85.63 on Friday. Cantel Medical Corp. has a 1-year low of $68.19 and a 1-year high of $88.81. The company has a market capitalization of $3.55 billion, a price-to-earnings ratio of 50.67 and a beta of 1.23. The stock has a 50 day moving average price of $78.63 and a 200 day moving average price of $76.61.

In related news, Chairman Charles M. Diker sold 35,000 shares of the company’s stock in a transaction that occurred on Wednesday, July 12th. The stock was sold at an average price of $75.52, for a total value of $2,643,200.00. Following the transaction, the chairman now directly owns 3,114,520 shares in the company, valued at $235,208,550.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 14.90% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Cantel Medical Corp. (CMD) Receiving Somewhat Positive News Coverage, Analysis Finds” was first reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another website, it was stolen and reposted in violation of U.S. & international copyright law. The original version of this piece of content can be viewed at https://www.watchlistnews.com/cantel-medical-corp-cmd-receiving-somewhat-positive-news-coverage-analysis-finds/1579201.html.

Cantel Medical Corp. Company Profile

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Insider Buying and Selling by Quarter for Cantel Medical Corp. (NYSE:CMD)

Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.